Cannabis for Palliative Care in Cancer
Part of paid clinical trials in Aurora, Colorado.
- Sponsor
- University of Colorado, Boulder
- Study ID
- NCT06266611
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Anxiety
- Depression
- Pain
- Sleep
Eligibility Criteria
- Sex
- ALL
- Age
- 25 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- fsCBD Cannabidiol — DRUGFull Spectrum hemp-derived CBD (fsCBD; 200mg CBD/4mg THC) capsules produced by Ecofibre/Ananda Hemp will be used
- Placebo — DRUGPlacebo arm; capsules produced by Ecofibre/Ananda Hemp will be used
- bsCBD Cannabidiol — DRUGBroad spectrum hemp-derived CBD (bsCBD; 200mg CBD) capsules produced by Ecofibre/Ananda Hemp will be used
Study Details
Many cancer patients suffer from pain, sleep, and mood problems and are using cannabis to relieve these symptoms. Cannabis may provide such relief but may also produce negative side effects including cognitive impairment, an especially problematic issue for cancer patients, indicating more research on cannabis use in the cancer context is required. In this endeavor, the present study seeks to compare the use of hemp-derived CBD (Cannabidiol) with and without THC (Delta-9-tetrahydrocannabinol) versus placebo on measures of sleep, pain, mood, subjective and objective cognitive functioning, and quality of life within 185 cancer patients.
Key Dates
- Start date
- Sep 16, 2024
- Status verified
- Jul 2025
- Primary completion
- May 30, 2028
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 185 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Full-Spectrum Hemp-Derived CBD (fsCBD)8 weeks of use of a daily dose of cannabis (200mg CBD/4mg THC)
- Experimental: Broad-Spectrum Hemp-Derived CBD (bsCBD)8 weeks of use of a daily dose of cannabis (200mg CBD)
- Placebo Comparator: Placebo
Primary Outcome Measure
Pain Interference [ Time Frame: Baseline, 4 weeks, 8 weeks ]
Central Contacts
- Kyle Chrystal, BA603-769-7718
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Anschutz Health Sciences Building | Aurora | Colorado | 80045 |
Find similar trials in Aurora, CO
Related Studies
- RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for PainRecruiting · Boston Scientific Corporation · Phoenix, Arizona
- Anesthetics and Analgesics in ChildrenRecruiting · Chi Dang Hornik · Stanford, California
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- Cognitive-Behavioral Therapy and Exercise Training in Adolescents At-Risk for Type 2 DiabetesRecruiting · Colorado State University · Aurora, Colorado